Delisting risk
Citius Oncology
Commercializing LYMPHIR for relapsed or refractory cutaneous T-cell lymphoma.
$0.7756
After-hours close−0.01 (−1.50%)
At close$0.7874(−0.37%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 15.32%14.25M sharesInsiders 6.58%6.12M sharesOther 78.10%72.61M shares
Shares outstanding 92.98M · Float 17.72M · 19.1% free float
Institutions13F, as of Mar 31, 2026
13 holders · 14.25M shares · 3 new positions · 9 increased · 1 reduced · 7 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Armistice Capital, LLC | 9.19M | 9.88% | +3.60M | May 15, 2026 |
| Bank of America Corp /DE/ | 3.84M | 4.12% | +3.83M | May 18, 2026 |
| Vanguard Capital Management LLC | 534.8K | 0.58% | +534.8Knew | May 15, 2026 |
| Geode Capital Management, LLC | 264.7K | 0.28% | +44.7K | May 15, 2026 |
| Vanguard Fiduciary Trust Co | 121.9K | 0.13% | +121.9Knew | May 8, 2026 |
| Ifp Advisors, Inc | 107.4K | 0.12% | +20.0K | Apr 13, 2026 |
| BlackRock, Inc. | 47.5K | 0.05% | +25.1K | May 13, 2026 |
| Northern Trust Corp | 45.7K | 0.05% | 0 | May 14, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Armistice Capital, LLC | 9.99% | 9.30M | 13G | May 15, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Leonard L. Mazur | director, officer: Chief Executive Officer | 1.70M | 1.83% | Sep 23, 2025 |
| Myron Z. Holubiak | director, officer: Secretary | 950.0K | 1.02% | Sep 23, 2025 |
| Jaime Bartushak | officer: Chief Financial Officer | 825.0K | 0.89% | Sep 23, 2025 |
| Myron Czuczman | officer: Chief Medical Officer | 825.0K | 0.89% | Sep 23, 2025 |
| Joel David Mayersohn | director | 321.2K | 0.35% | Sep 23, 2025 |
| Suren G. Dutia | director | 300.0K | 0.32% | Sep 23, 2025 |
| Eugene Myron Holuka | director | 300.0K | 0.32% | Sep 23, 2025 |
| Dennis M. Mcgrath | director | 300.0K | 0.32% | Sep 23, 2025 |
| Robert Joseph Smith | director | 300.0K | 0.32% | Sep 23, 2025 |
| Carol Webb | director | 300.0K | 0.32% | Sep 23, 2025 |
1 ten-percent owner holds 65.63M shares by Form 4, outside the officers-and-directors figure above
Latest trades
No open-market trades in the last 12 months.
CongressHouse and Senate disclosures
Not reported.